HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-160 Cr | ₹-144 Cr | ₹-27 Cr | ₹-7.68 Cr | ₹-5.56 Cr |
What is the latest Cash Flow from Financing Activities ratio of HIKAL ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-160 Cr |
| Mar2025 | ₹-144 Cr |
| Mar2024 | ₹-27 Cr |
| Mar2023 | ₹-7.68 Cr |
| Mar2022 | ₹-5.56 Cr |
How is Cash Flow from Financing Activities of HIKAL Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-160 Cr | Negative | |
| Mar2025 | ₹-144 Cr | Negative | |
| Mar2024 | ₹-27 Cr | Negative | |
| Mar2023 | ₹-7.68 Cr | Negative | |
| Mar2022 | ₹-5.56 Cr | - | |
Compare Cash Flow from Financing Activities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,753.9 Cr | -2.9% | 1.2% | -9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -2.9% |
1.2% |
-9% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses